Distinguished in Allergic Conjunctivitis

Stephen R. Durham

London, ENG, GB 
Distinguished in Allergic Conjunctivitis
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Stephen Durham practices in London, United Kingdom. Mr. Durham is rated as a Distinguished expert by MediFind in the treatment of Allergic Conjunctivitis. His top areas of expertise are Grass Allergy, Giant Papillary Conjunctivitis, Allergic Rhinitis, Vernal Keratoconjunctivitis, and Endoscopy.

His clinical research consists of co-authoring 195 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Allergic Conjunctivitis.

Gender
Male

Locations

London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Grass Pollen Sublingual Tablet Immunotherapy Plus Dupilumab for Induction of Tolerance in Adults With Moderate to Severe Seasonal Allergic Rhinitis (ITN084AD)
Grass Pollen Sublingual Tablet Immunotherapy Plus Dupilumab for Induction of Tolerance in Adults With Moderate to Severe Seasonal Allergic Rhinitis (ITN084AD)
Enrollment Status: Completed
Publish Date: July 15, 2025
Intervention Type: Drug, Biological
Study Drugs: Dupilumab, Grazax Timothy Grass/Grass Pollen Vaccine
Study Phase: Phase 2
Nasal Allergen Challenge: Standardisation as a Surrogate for Hay Fever
Nasal Allergen Challenge: Standardisation as a Surrogate for Hay Fever
Enrollment Status: Completed
Publish Date: August 31, 2021
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 1 Less Clinical Trial

195 Total Publications

Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response.
Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response.
Journal: Immunity
Published: July 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Durham's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile